Expansion of QIAseq portfolio to Long Read Panels enables high-resolution analysis of complex genomic regions using long-read sequencing Supports NG...
HMNC Brain Health (“HMNC”), a global precision psychiatry biopharmaceutical company, in collaboration with Spruce Biosciences, Inc. (OTCQB: S...
Carestream Health recently secured an agreement with Vietnam South East Asia Joint Stock Company (VISTACOM), a leading distributor of advanced medical eq...
Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test to rule out Alzheimer’s associated amyloid pathology. The mini...
Everlab, the AI-powered health platform reimagining preventive care, announced a US$10 million (AU$15 million) seed round led by global growth equity fir...
Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, ra...
Adalvo was founded in 2018 by Aztiq and is one of the leading business-to-business pharmaceutical companies in Europe EQT will support Adalvo’s ...
In this BioPharma Boardroom discussion, we speak with Christophe Hotermans, Head of Global Medical Affairs at Alexion, AstraZeneca Rare Disease. From the e...
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a ...
Omega Healthcare, a leading provider of technology-enabled RCM services, announced an expanded collaboration with Microsoft to further enhance its ...
iFIT, a global leader in connected fitness and interactive content, announced a groundbreaking partnership with Samsung Health, one of the world&rs...
Golden Age Health Pte. Ltd. (“GAH”) and Innostellar Biotherapeutics Co., Ltd. (“Innostellar”) announced an exclusive ten-ye...
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced that the European Medicines Agency (EMA) will lift the tempo...
SimBioSys®, a clinical AI company leveraging spatial biophysics to drive precision in breast cancer treatment, today announced its third FDA 510(k) c...
© 2025 Biopharma Boardroom. All Rights Reserved.
